Clinical Trial Update: Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Bevacizumab, Gemcitabine, and Oxaliplatin in metastatic pancreatic cancer has completed; the update outlines safety and preliminary e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED